These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17927471)

  • 1. European regulatory conundrum of phage therapy.
    Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP
    Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting.
    Huys I; Vaneechoutte M; Verbeken G; Debarbieux L
    Res Microbiol; 2013 Sep; 164(7):806-10. PubMed ID: 23583722
    [No Abstract]   [Full Text] [Related]  

  • 3. Phage approved in food, why not as a therapeutic?
    Sarhan WA; Azzazy HM
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):91-101. PubMed ID: 25488141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage cocktails and the future of phage therapy.
    Chan BK; Abedon ST; Loc-Carrillo C
    Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phage therapy: harmless viruses help destroy bacterial infections].
    van Bergen M; Wagenaar J
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):618-21. PubMed ID: 18767304
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages as twenty-first century antibacterial tools for food and medicine.
    Maura D; Debarbieux L
    Appl Microbiol Biotechnol; 2011 May; 90(3):851-9. PubMed ID: 21491205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage therapy: quo vadis?
    Brüssow H
    Clin Infect Dis; 2014 Feb; 58(4):535-6. PubMed ID: 24270168
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.
    Verbeken G; Huys I; De Vos D; De Coninck A; Roseeuw D; Kets E; Vanderkelen A; Draye JP; Rose T; Jennes S; Ceulemans C; Pirnay JP
    FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26678555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 12. Revisiting phage therapy: new applications for old resources.
    Nobrega FL; Costa AR; Kluskens LD; Azeredo J
    Trends Microbiol; 2015 Apr; 23(4):185-91. PubMed ID: 25708933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage therapy.
    Housby JN; Mann NH
    Drug Discov Today; 2009 Jun; 14(11-12):536-40. PubMed ID: 19508915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial bioagents based on principles of bacteriophage biology: an overview.
    Knoll BM; Mylonakis E
    Clin Infect Dis; 2014 Feb; 58(4):528-34. PubMed ID: 24270166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriophages as antibacterial agents].
    Shasha SM; Sharon N; Inbar M
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bacteriophage journey at the European Medicines Agency.
    Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C
    FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is needed for phage therapy to become a reality in Western medicine?
    Brüssow H
    Virology; 2012 Dec; 434(2):138-42. PubMed ID: 23059181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection therapy: the problem of drug resistance - and possible solutions.
    Brüssow H
    Microb Biotechnol; 2017 Sep; 10(5):1041-1046. PubMed ID: 28737021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.